Back To Search Instructions
6 protocols meet the specified criteria
Disease Site: Soft Tissue
Protocol No.TitleStatus
0500000013D9902: A COG Soft Tissue Biology and Banking ProtocolOpen
1501622398COG ARST1321: Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus PazopanibOpen
1507012651A Randomized, Open-label, Phase II, Multi-center Trial of Gemcitabine (G) with Pazopanib (P) or Gemcitabine (G) with Docetaxel (T) in Previously Treated Subjects with Advanced Soft Tissue SarcomaOpen
1606636756ARST1431: A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide Alternating with Vincristine and Irinotecan Versus VAC/VI Plus Temsirolimus in Patients with Intermediate Risk RhabdomyosarcomaOpen
1704390293A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab anti-PD-1 Monoclonal Antibody) and in Combination with Both Nivolumab and Ipilimumab (anti-CTLA-4 Monoclonal Antibody) in Advanced Malignant TumorsOpen
1705411350A Randomized Phase III Trial Of TRC105 And Pazopanib Versus Pazopanib Alone In Patients With Advanced Angiosarcoma (Tappas) Open